President and CEO
Autonomix Medical
Mr. Hauser is a medical device executive with extensive experience leading clinical development, R&D, operations, and commercialization of novel technologies in regulated healthcare markets. His background spans the full translational pathway, from early clinical investigation and FDA engagement through market introduction and clinical adoption. As CEO of Soliton, Inc., he led the RESONIC platform through clinical evaluation, FDA clearance, and acquisition by Allergan Aesthetics, an AbbVie company. Previously, he played a central role in the clinical and commercial expansion of the CoolSculpting platform at Zeltiq Aesthetics prior to its acquisition by Allergan.
Disclosure(s): Autonomix Medical: Employee (Ongoing); Candela Medical: Board Member (Ongoing)
Illuminating the Nervous System With Transvascular Precision-Guided Technology
Monday, March 9, 2026
4:19 PM - 4:27 PM EST